Stay updated on Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5 on the Study Record History page. This reflects a routine platform/UI release associated with updating the page's history display.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new revision entry (v3.5.4) is added to the history, replacing the previous revision (v3.5.3). This indicates a software or UI update recorded in the page's version log and reflects an updated version of the history page itself.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedA new revision entry, Revision: v3.5.3, was added to the study's record history, indicating the latest version of the study record. The update replaces the previous v3.5.2 entry in the history.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page history shows a new site revision (v3.5.2) and removal of the previous revision (v3.5.0).SummaryDifference0.1%

- Check77 days agoChange DetectedRevision: v3.5.0 was added to the history and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded a Study Status section to the Record History page and updated to Revision: v3.4.3 (2026-03-09). The previous revision v3.4.2 (2025-12-26) was deleted.SummaryDifference0.3%

Stay in the know with updates to Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.